GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » Gross-Profit-to-Asset %

ASEP Medical Holdings (ASEP Medical Holdings) Gross-Profit-to-Asset % : 1.06% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. ASEP Medical Holdings's annualized Gross Profit for the quarter that ended in Mar. 2024 was $0.20 Mil. ASEP Medical Holdings's average Total Assets over the quarter that ended in Mar. 2024 was $18.87 Mil. Therefore, ASEP Medical Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 1.06%.


ASEP Medical Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for ASEP Medical Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASEP Medical Holdings Gross-Profit-to-Asset % Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
-0.02 -0.52 -0.44

ASEP Medical Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.30 -0.58 -0.89 1.06

Competitive Comparison of ASEP Medical Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, ASEP Medical Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASEP Medical Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's Gross-Profit-to-Asset % falls into.



ASEP Medical Holdings Gross-Profit-to-Asset % Calculation

ASEP Medical Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-0.085/( (19.933+19.091)/ 2 )
=-0.085/19.512
=-0.44 %

ASEP Medical Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0.2/( (19.091+18.641)/ 2 )
=0.2/18.866
=1.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


ASEP Medical Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Traded in Other Exchanges
Address
730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7
ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.

ASEP Medical Holdings (ASEP Medical Holdings) Headlines

From GuruFocus

Asep Inc. Undertakes Final Steps Toward NASDAQ Listing

By PRNewswire PRNewswire 06-17-2023